Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Schedule of Earnings Per Share Anti-diluted

The following financial instruments were not included in the diluted loss per share calculation as of March 31, 2023 and 2022 because their effect was anti-dilutive:

	As of March 31,
	2023		2022
Warrants to purchase common stock		712,500		962,794
Options		1,170,000		1,235,000
Non-vested restricted stock awards units		1,631,399		1,668,084
Total		3,513,899		3,865,878